Early  ||| S:0 E:6 ||| RB
enteral  ||| S:6 E:14 ||| JJ
feeding  ||| S:14 E:22 ||| NN
with  ||| S:22 E:27 ||| IN
human  ||| S:27 E:33 ||| JJ
milk  ||| S:33 E:38 ||| NN
for  ||| S:38 E:42 ||| IN
VLBW  ||| S:42 E:47 ||| NNP
infants  ||| S:47 E:55 ||| NNS
In  ||| S:55 E:58 ||| IN
a  ||| S:58 E:60 ||| DT
NICU  ||| S:60 E:65 ||| NNP
early  ||| S:65 E:71 ||| RB
enteral  ||| S:71 E:79 ||| JJ
feeding  ||| S:79 E:87 ||| NN
is  ||| S:87 E:90 ||| VBZ
usually  ||| S:90 E:98 ||| RB
possible  ||| S:98 E:107 ||| JJ
only  ||| S:107 E:112 ||| RB
when  ||| S:112 E:117 ||| WRB
the  ||| S:117 E:121 ||| DT
newborn  ||| S:121 E:129 ||| JJ
clinical  ||| S:129 E:138 ||| JJ
conditions  ||| S:138 E:149 ||| NNS
permit  ||| S:149 E:156 ||| VBP
it ||| S:156 E:158 ||| PRP
.  ||| S:158 E:160 ||| .
Because  ||| S:160 E:168 ||| IN
of  ||| S:168 E:171 ||| IN
the  ||| S:171 E:175 ||| DT
frequent  ||| S:175 E:184 ||| JJ
need  ||| S:184 E:189 ||| NN
of  ||| S:189 E:192 ||| IN
umbilical ||| S:192 E:201 ||| CD
/ ||| S:201 E:202 ||| CD
central  ||| S:202 E:210 ||| JJ
catheters ||| S:210 E:219 ||| NNS
,  ||| S:219 E:221 ||| ,
they  ||| S:221 E:226 ||| PRP
usually  ||| S:226 E:234 ||| RB
start  ||| S:234 E:240 ||| VB
with  ||| S:240 E:245 ||| IN
parenteral  ||| S:245 E:256 ||| JJ
feeding  ||| S:256 E:264 ||| NN
and ||| S:264 E:267 ||| CC
/ ||| S:267 E:268 ||| NNP
or  ||| S:268 E:271 ||| CC
with  ||| S:271 E:276 ||| IN
minimal  ||| S:276 E:284 ||| JJ
enteral  ||| S:284 E:292 ||| JJ
feeding  ||| S:292 E:300 ||| NN
( ||| S:300 E:301 ||| -LRB-
trophic  ||| S:301 E:309 ||| FW
feeding ||| S:309 E:316 ||| FW
) ||| S:316 E:317 ||| -RRB-
.  ||| S:317 E:319 ||| .
This  ||| S:319 E:324 ||| DT
kind  ||| S:324 E:329 ||| NN
of  ||| S:329 E:332 ||| IN
management  ||| S:332 E:343 ||| NN
is  ||| S:343 E:346 ||| VBZ
even  ||| S:346 E:351 ||| RB
more  ||| S:351 E:356 ||| RBR
frequent  ||| S:356 E:365 ||| JJ
in  ||| S:365 E:368 ||| IN
VLBWIs ||| S:368 E:374 ||| NNP
,  ||| S:374 E:376 ||| ,
in  ||| S:376 E:379 ||| IN
which  ||| S:379 E:385 ||| WDT
the  ||| S:385 E:389 ||| DT
risk  ||| S:389 E:394 ||| NN
of  ||| S:394 E:397 ||| IN
NEC  ||| S:397 E:401 ||| NNP
is  ||| S:401 E:404 ||| VBZ
very  ||| S:404 E:409 ||| RB
high ||| S:409 E:413 ||| JJ
.  ||| S:413 E:415 ||| .
In  ||| S:415 E:418 ||| IN
this  ||| S:418 E:423 ||| DT
work  ||| S:423 E:428 ||| NN
we  ||| S:428 E:431 ||| PRP
describe  ||| S:431 E:440 ||| VBP
a  ||| S:440 E:442 ||| DT
model  ||| S:442 E:448 ||| NN
of  ||| S:448 E:451 ||| IN
early  ||| S:451 E:457 ||| JJ
enteral  ||| S:457 E:465 ||| JJ
exclusive  ||| S:465 E:475 ||| JJ
feeding  ||| S:475 E:483 ||| NN
( ||| S:483 E:484 ||| -LRB-
EEEF ||| S:484 E:488 ||| NNP
)  ||| S:488 E:490 ||| -RRB-
based  ||| S:490 E:496 ||| VBN
on  ||| S:496 E:499 ||| IN
the  ||| S:499 E:503 ||| DT
use  ||| S:503 E:507 ||| NN
of  ||| S:507 E:510 ||| IN
banking  ||| S:510 E:518 ||| VBG
human  ||| S:518 E:524 ||| JJ
milk  ||| S:524 E:529 ||| NN
followed  ||| S:529 E:538 ||| VBN
by  ||| S:538 E:541 ||| IN
mother  ||| S:541 E:548 ||| NN
milk ||| S:548 E:552 ||| NN
.  ||| S:552 E:554 ||| .
In  ||| S:554 E:557 ||| IN
the  ||| S:557 E:561 ||| DT
Centre  ||| S:561 E:568 ||| NNP
of  ||| S:568 E:571 ||| IN
Neonatology  ||| S:571 E:583 ||| NNP
of  ||| S:583 E:586 ||| IN
Trento ||| S:586 E:592 ||| NNP
,  ||| S:592 E:594 ||| ,
as  ||| S:594 E:597 ||| RB
in  ||| S:597 E:600 ||| IN
other  ||| S:600 E:606 ||| JJ
Centers ||| S:606 E:613 ||| NNPS
,  ||| S:613 E:615 ||| ,
the  ||| S:615 E:619 ||| DT
newborns  ||| S:619 E:628 ||| NN
weighing  ||| S:628 E:637 ||| VBG
less  ||| S:637 E:642 ||| JJR
than  ||| S:642 E:647 ||| IN
750g  ||| S:647 E:652 ||| NNP
or  ||| S:652 E:655 ||| CC
with  ||| S:655 E:660 ||| IN
a  ||| S:660 E:662 ||| DT
GE  ||| S:662 E:664 ||| NNP
< ||| S:664 E:666 ||| SYM
27  ||| S:666 E:669 ||| CD
weeks ||| S:669 E:674 ||| NNS
,  ||| S:674 E:676 ||| ,
are  ||| S:676 E:680 ||| VBP
treated  ||| S:680 E:688 ||| VBN
with  ||| S:688 E:693 ||| IN
parenteral  ||| S:693 E:704 ||| JJ
nutrition  ||| S:704 E:714 ||| NN
and  ||| S:714 E:718 ||| CC
minimal  ||| S:718 E:726 ||| JJ
enteral  ||| S:726 E:734 ||| JJ
feeding ||| S:734 E:741 ||| NN
.  ||| S:741 E:743 ||| .
The  ||| S:743 E:747 ||| DT
newborn  ||| S:747 E:755 ||| NN
weighing  ||| S:755 E:764 ||| VBG
750-1249g  ||| S:764 E:774 ||| NNP
and  ||| S:774 E:778 ||| CC
with  ||| S:778 E:783 ||| IN
GE  ||| S:783 E:786 ||| NNP
>  ||| S:786 E:788 ||| CD
26  ||| S:788 E:791 ||| CD
weeks  ||| S:791 E:797 ||| NNS
define  ||| S:797 E:804 ||| VB
a  ||| S:804 E:806 ||| DT
group  ||| S:806 E:812 ||| NN
in  ||| S:812 E:815 ||| IN
which  ||| S:815 E:821 ||| WDT
we  ||| S:821 E:824 ||| PRP
find  ||| S:824 E:829 ||| VBP
critical  ||| S:829 E:838 ||| JJ
neonates ||| S:838 E:846 ||| NN
,  ||| S:846 E:848 ||| ,
who  ||| S:848 E:852 ||| WP
can  ||| S:852 E:856 ||| MD
not  ||| S:856 E:860 ||| RB
be  ||| S:860 E:863 ||| VB
treated  ||| S:863 E:871 ||| VBN
with  ||| S:871 E:876 ||| IN
enteral  ||| S:876 E:884 ||| JJ
feeding ||| S:884 E:891 ||| NN
,  ||| S:891 E:893 ||| ,
and  ||| S:893 E:897 ||| CC
neonates  ||| S:897 E:906 ||| NNS
whose  ||| S:906 E:912 ||| WP$
clinical  ||| S:912 E:921 ||| JJ
conditions  ||| S:921 E:932 ||| NNS
permit  ||| S:932 E:939 ||| VBP
EEEF ||| S:939 E:943 ||| NNP
.  ||| S:943 E:945 ||| .
In  ||| S:945 E:948 ||| IN
particular ||| S:948 E:958 ||| JJ
,  ||| S:958 E:960 ||| ,
in  ||| S:960 E:963 ||| IN
a  ||| S:963 E:965 ||| DT
period  ||| S:965 E:972 ||| NN
of  ||| S:972 E:975 ||| IN
16  ||| S:975 E:978 ||| CD
years  ||| S:978 E:984 ||| NNS
( ||| S:984 E:985 ||| -LRB-
1994-2009 ||| S:985 E:994 ||| NNP
)  ||| S:994 E:996 ||| -RRB-
in  ||| S:996 E:999 ||| IN
Trento ||| S:999 E:1005 ||| NNP
,  ||| S:1005 E:1007 ||| ,
308  ||| S:1007 E:1011 ||| CD
newborns  ||| S:1011 E:1020 ||| NNS
weighing  ||| S:1020 E:1029 ||| VBG
750-1249  ||| S:1029 E:1038 ||| CD
g  ||| S:1038 E:1040 ||| NNS
and  ||| S:1040 E:1044 ||| CC
GE  ||| S:1044 E:1047 ||| NNP
>  ||| S:1047 E:1049 ||| NNP
than  ||| S:1049 E:1054 ||| IN
26  ||| S:1054 E:1057 ||| CD
weeks  ||| S:1057 E:1063 ||| NNS
were  ||| S:1063 E:1068 ||| VBD
admitted ||| S:1068 E:1076 ||| VBN
.  ||| S:1076 E:1078 ||| .
The  ||| S:1078 E:1082 ||| DT
90 ||| S:1082 E:1084 ||| CD
, ||| S:1084 E:1085 ||| ,
9  ||| S:1085 E:1087 ||| CD
%  ||| S:1087 E:1089 ||| NN
has  ||| S:1089 E:1093 ||| VBZ
been  ||| S:1093 E:1098 ||| VBN
treated  ||| S:1098 E:1106 ||| VBN
with  ||| S:1106 E:1111 ||| IN
prenatal  ||| S:1111 E:1120 ||| JJ
steroids ||| S:1120 E:1128 ||| NNS
,  ||| S:1128 E:1130 ||| ,
the  ||| S:1130 E:1134 ||| DT
91 ||| S:1134 E:1136 ||| CD
, ||| S:1136 E:1137 ||| ,
9  ||| S:1137 E:1139 ||| CD
%  ||| S:1139 E:1141 ||| NN
was  ||| S:1141 E:1145 ||| VBD
inborn ||| S:1145 E:1151 ||| CD
,  ||| S:1151 E:1153 ||| ,
the  ||| S:1153 E:1157 ||| DT
96,1 ||| S:1157 E:1161 ||| JJ
%  ||| S:1161 E:1163 ||| NN
survived ||| S:1163 E:1171 ||| VBD
.  ||| S:1171 E:1173 ||| .
In  ||| S:1173 E:1176 ||| IN
the  ||| S:1176 E:1180 ||| DT
59 ||| S:1180 E:1182 ||| CD
, ||| S:1182 E:1183 ||| ,
1  ||| S:1183 E:1185 ||| CD
%  ||| S:1185 E:1187 ||| NN
of  ||| S:1187 E:1190 ||| IN
the  ||| S:1190 E:1194 ||| DT
cases  ||| S:1194 E:1200 ||| NNS
( ||| S:1200 E:1201 ||| -LRB-
175 ||| S:1201 E:1204 ||| CD
)  ||| S:1204 E:1206 ||| -RRB-
we  ||| S:1206 E:1209 ||| PRP
gave  ||| S:1209 E:1214 ||| VBD
EEEF ||| S:1214 E:1218 ||| NNP
.  ||| S:1218 E:1220 ||| .
We  ||| S:1220 E:1223 ||| PRP
could  ||| S:1223 E:1229 ||| MD
continue  ||| S:1229 E:1238 ||| VB
with  ||| S:1238 E:1243 ||| IN
a  ||| S:1243 E:1245 ||| DT
complete  ||| S:1245 E:1254 ||| JJ
EEEF  ||| S:1254 E:1259 ||| NN
in  ||| S:1259 E:1262 ||| IN
the  ||| S:1262 E:1266 ||| DT
40 ||| S:1266 E:1268 ||| CD
, ||| S:1268 E:1269 ||| ,
2  ||| S:1269 E:1271 ||| CD
%  ||| S:1271 E:1273 ||| NN
of  ||| S:1273 E:1276 ||| IN
the  ||| S:1276 E:1280 ||| DT
total  ||| S:1280 E:1286 ||| NN
( ||| S:1286 E:1287 ||| -LRB-
119  ||| S:1287 E:1291 ||| CD
cases ||| S:1291 E:1296 ||| NNS
) ||| S:1296 E:1297 ||| -RRB-
.  ||| S:1297 E:1299 ||| .
The  ||| S:1299 E:1303 ||| DT
characteristics  ||| S:1303 E:1319 ||| NN
of  ||| S:1319 E:1322 ||| IN
these  ||| S:1322 E:1328 ||| DT
neonates  ||| S:1328 E:1337 ||| NN
and  ||| S:1337 E:1341 ||| CC
our  ||| S:1341 E:1345 ||| PRP$
centre  ||| S:1345 E:1352 ||| JJ
management ||| S:1352 E:1362 ||| NN
,  ||| S:1362 E:1364 ||| ,
based  ||| S:1364 E:1370 ||| VBN
mainly  ||| S:1370 E:1377 ||| RB
on  ||| S:1377 E:1380 ||| IN
early  ||| S:1380 E:1386 ||| JJ
use  ||| S:1386 E:1390 ||| NN
of  ||| S:1390 E:1393 ||| IN
banking  ||| S:1393 E:1401 ||| VBG
human  ||| S:1401 E:1407 ||| JJ
milk  ||| S:1407 E:1412 ||| NN
and  ||| S:1412 E:1416 ||| CC
mother  ||| S:1416 E:1423 ||| NN
milk ||| S:1423 E:1427 ||| NN
,  ||| S:1427 E:1429 ||| ,
are  ||| S:1429 E:1433 ||| VBP
detailed  ||| S:1433 E:1442 ||| VBN
described ||| S:1442 E:1451 ||| VBN
.  ||| S:1451 E:1453 ||| .
